Navigation Links
Nobel Prize Winner Professor Muhammad Yunus Leading Delegation From Bangladesh to World Health Care Congress to Advance Affordable Health Care Innovations
Date:4/7/2009

Health Care innovations and opportunities attract attendees from more than 35 countries and delegations from over 12 to the 6th Annual World Health Care Congress April 14-16, 2009, Washington, D.C.

WASHINGTON, April 7 /PRNewswire/ -- Professor Muhammad Yunus of the Grameen Bank and a delegation of 12 leaders from Bangladesh will be joining delegations from more than a dozen other countries at the 6th Annual World Health Care Congress, April 14-16, Washington, D.C. Professor Yunus, a 2006 Nobel Peace Prize Laureate will be speaking at the conference regarding the Grameen Healthcare initiative, a program to develop a world-class, sustainable health care network to serve the people of Bangladesh.

"A vital component of our health programs is the accompanying micro-health insurance program to encourage positive health seeking practices. This serves a dual purpose of enhancing utilization of health services and improving cost-recovery to achieve sustainability," states Professor Yunus. "While initial evaluations of the Grameen Clinic network and its health impact are positive, continuous improvements in coverage, disease prevention, quality of care and sustainability remain as top priorities."

The Bangladeshi delegation will be joined by others who will represent the spectrum of foreign health care leaders, from health ministries to hospitals, medical research facilities, pharmaceuticals and media outlets. This year's congress will feature delegations from: China, India, Israel, Romania, United Kingdom, Switzerland, Sweden, South Africa, Poland, Germany, France, Czech Republic, Denmark, Canada, and Nigeria. Representatives from more than 35 other countries are also registered.

Countries such as China also will be represented with pavilions that highlight companies that are shaping the future of health care delivery in their home countries.

"The World Health Care
'/>"/>

SOURCE World Health Care Congress
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Thomson Scientific Predicts Nobel Laureates
2. 2007 EURYI: 20 researchers to receive Nobel Prize-sized awards in Helsinki
3. Two more American Cancer Society researchers win Nobel Prize
4. Nobel Honors 3 Former March of Dimes Prize Recipients
5. Hurricane Katrina Doctor and Nobel Laureate Headline ASCP Annual Meeting
6. Bottomless bowls are an Ig Nobel winner
7. 9 Wiley authors win Nobel Prizes
8. Gloomy forecast for Nobel Direct after 3 years
9. Whole Planet Foundation(TM) (a Whole Foods Market Foundation) and Nobel Peace Prize Winner Dr. Muhammad Yunus Partner With Natural Foods Vendors, Pledging Over $1 Million to Help Combat Poverty
10. Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee
11. Computer games high score could earn the Nobel Prize in medicine
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:183 New Medicines in Development for Diabetes 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Ikaria 28R 29 Names New Chairman 14523 1Ikaria 28R 29 Names New Chairman 14523 2Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 1Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 2Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 3Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 4Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 5Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 6Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 7Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 1Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 2Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 3